Our region has abundant straw and sweet potato resources, and local farmers have the habit of using sweet potatoes to produce fans through biofermentation. However, most of the potato residues produced after the production of fans were wasted except for a small portion of livestock. In order to make full use of this resource, the author conducted experiments on mixed cultivation of Hericium erinaceus with rice straw and potato residue. The following is introduced for reference. 1, selection. Select mycelium vitality, mushroom shape, fast growth, strong resistance and other fine bacteria. Mother cultivars use PDA medium. The original species uses wood chips and wheat bran. 2, culture ingredients formula. 43% straw, 43% sweet potato residue, 12% corn flour, 1% gypsum powder, 0.5% superphosphate, and 0.5% sucrose. 171 grams per bottle. 3, cultivation methods. Choose fresh mildew-free straw, cut into small pieces of 1.5-2 cm, soak it in 1.5% lime water for 8 hours. Rinse with clean water and drain. Combine with other ingredients. pH5 or so. Mix 750 ml of bacteria. The bottle was sealed with kraft paper and autoclaved for 1 hour to remove the pot. The temperature was lowered below 26°C and inoculated. The culture was incubated at 22-27°C. When the mycelium full bottle begins to form a fruit body, the seal is peeled off, and the mushroom is opened under the condition of 15-20°C and air humidity of 80%-90%. Spray water 1-2 times a day. Hericium erinaceus cultivated by this method has high yield and high biological efficiency.
Respiratory disease is a common disease, frequently-occurring disease, the main lesion in the trachea, bronchi, lung and chest, lesions are more cough, chest pain, respiratory effects, severe breathing difficulties, hypoxia, and even respiratory failure and death. Due to air pollution, smoking and other factors, The chronic obstructive pulmonary disease is increasing including chronic bronchitis, emphysema, pulmonary heart disease, bronchial asthma, lung cancer, pulmonary diffuse interstitial fibrosis, and pulmonary infection the morbidity and mortality of the disease at home and abroad . Therefore, Anti-Respiratory disease drugs are also more and more attention paid by researchers. Respiratory disease have the symptoms of cough, sputum, hemoptysis, chest pain, shortness of breath and other symptoms of lack of specificity, often clinicians mistaken by people for colds, bronchitis, and severe pneumonia, tuberculosis or lung cancer and other diseases delayed diagnosis; Respiratory tract infection, to be developed to emphysema, pulmonary heart disease, respiratory failure was taken seriously, but it was too late, its pathology and physiological function has been difficult to reverse. As with other systemic diseases, careful and detailed medical history and physical examination are the basis for the diagnosis of respiratory diseases, and should be combined with routine laboratory tests and other special findings to conduct a comprehensive and comprehensive analysis. Currently the most clinical application of anti-respiratory disease drugs have the following four categories: 1. Antihistamines 2. Cough medicine 3. Bronchodilator 4. Expectorant 5. Anti-asthma Drugs.
Anti-Respiratory Anti-asthma Drugs, Antitussives, Expectorants, β adrenergic receptor agonists, M Cholinergic Blockers, Phosphodiesterase Inhibitors, Anti-Respiratory Drugs,Respiratory System Diseases Treatment Taizhou Volsen Chemical Co., Ltd. , http://www.volsenchem.com